SIGL7_HUMAN - dbPTM
SIGL7_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SIGL7_HUMAN
UniProt AC Q9Y286
Protein Name Sialic acid-binding Ig-like lectin 7
Gene Name SIGLEC7
Organism Homo sapiens (Human).
Sequence Length 467
Subcellular Localization Membrane
Single-pass type I membrane protein.
Protein Description Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- and alpha-2,6-linked sialic acid. Also binds disialogangliosides (disialogalactosyl globoside, disialyl lactotetraosylceramide and disialyl GalNAc lactotetraoslylceramide). The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. Mediates inhibition of natural killer cells cytotoxicity. May play a role in hemopoiesis. Inhibits differentiation of CD34+ cell precursors towards myelomonocytic cell lineage and proliferation of leukemic myeloid cells (in vitro)..
Protein Sequence MLLLLLLPLLWGRERVEGQKSNRKDYSLTMQSSVTVQEGMCVHVRCSFSYPVDSQTDSDPVHGYWFRAGNDISWKAPVATNNPAWAVQEETRDRFHLLGDPQTKNCTLSIRDARMSDAGRYFFRMEKGNIKWNYKYDQLSVNVTALTHRPNILIPGTLESGCFQNLTCSVPWACEQGTPPMISWMGTSVSPLHPSTTRSSVLTLIPQPQHHGTSLTCQVTLPGAGVTTNRTIQLNVSYPPQNLTVTVFQGEGTASTALGNSSSLSVLEGQSLRLVCAVDSNPPARLSWTWRSLTLYPSQPSNPLVLELQVHLGDEGEFTCRAQNSLGSQHVSLNLSLQQEYTGKMRPVSGVLLGAVGGAGATALVFLSFCVIFIVVRSCRKKSARPAADVGDIGMKDANTIRGSASQGNLTESWADDNPRHHGLAAHSSGEEREIQYAPLSFHKGEPQDLSGQEATNNEYSEIKIPK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
105N-linked_GlycosylationLGDPQTKNCTLSIRD
CCCCCCCCCEEEEEE
27.6516895906
109PhosphorylationQTKNCTLSIRDARMS
CCCCCEEEEEEECHH
9.4524719451
142N-linked_GlycosylationKYDQLSVNVTALTHR
EECEEEEEEEEECCC
23.26UniProtKB CARBOHYD
165N-linked_GlycosylationLESGCFQNLTCSVPW
CCCCCCCCCEECCCC
19.64UniProtKB CARBOHYD
229N-linked_GlycosylationPGAGVTTNRTIQLNV
CCCCCEECCEEEEEE
29.72UniProtKB CARBOHYD
235N-linked_GlycosylationTNRTIQLNVSYPPQN
ECCEEEEEEECCCCC
12.33UniProtKB CARBOHYD
242N-linked_GlycosylationNVSYPPQNLTVTVFQ
EEECCCCCEEEEEEE
43.37UniProtKB CARBOHYD
260N-linked_GlycosylationTASTALGNSSSLSVL
CCEEECCCCCCEEEE
39.30UniProtKB CARBOHYD
334N-linked_GlycosylationGSQHVSLNLSLQQEY
CCCEEEEEEEEEEHH
21.78UniProtKB CARBOHYD
349PhosphorylationTGKMRPVSGVLLGAV
CCCCCCCCCEEHHCC
26.35-
362PhosphorylationAVGGAGATALVFLSF
CCCHHHHHHHHHHHH
21.43-
400PhosphorylationIGMKDANTIRGSASQ
CCCCCCCCCCCCCCC
17.4827486199
404PhosphorylationDANTIRGSASQGNLT
CCCCCCCCCCCCCCC
18.2026657352
406PhosphorylationNTIRGSASQGNLTES
CCCCCCCCCCCCCCC
40.0728355574
411PhosphorylationSASQGNLTESWADDN
CCCCCCCCCCCCCCC
31.7928450419
413PhosphorylationSQGNLTESWADDNPR
CCCCCCCCCCCCCCC
23.4828450419
428PhosphorylationHHGLAAHSSGEEREI
CCCCCCCCCCCCEEE
35.0024275569
429PhosphorylationHGLAAHSSGEEREIQ
CCCCCCCCCCCEEEE
40.1216895906
437PhosphorylationGEEREIQYAPLSFHK
CCCEEEEEECCEECC
18.8228258704
441PhosphorylationEIQYAPLSFHKGEPQ
EEEEECCEECCCCCC
25.0128258704
460PhosphorylationQEATNNEYSEIKIPK
CCCCCCCCCCCCCCC
17.4625587033
461PhosphorylationEATNNEYSEIKIPK-
CCCCCCCCCCCCCC-
27.02-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseSOCS3O14543
PMID:17138568

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SIGL7_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SIGL7_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LG3BP_HUMANLGALS3BPphysical
25320078
WDR89_HUMANWDR89physical
28514442
LEG1_HUMANLGALS1physical
28514442
PTN6_HUMANPTPN6physical
15703304
PTN11_HUMANPTPN11physical
15703304

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SIGL7_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Siglec-7 undergoes a major conformational change when complexed withthe alpha(2,8)-disialylganglioside GT1b.";
Attrill H., Imamura A., Sharma R.S., Kiso M., Crocker P.R.,van Aalten D.M.;
J. Biol. Chem. 281:32774-32783(2006).
Cited for: X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 18-144 IN COMPLEX WITHALPHA(2,8)-DISIALYLATED LIGAND GT1B, GLYCOSYLATION AT ASN-105, ANDDISULFIDE BOND.
"The structure of siglec-7 in complex with sialosides: leads forrational structure-based inhibitor design.";
Attrill H., Takazawa H., Witt S., Kelm S., Isecke R., Brossmer R.,Ando T., Ishida H., Kiso M., Crocker P.R., van Aalten D.M.;
Biochem. J. 397:271-278(2006).
Cited for: X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 18-144 IN COMPLEX WITHSIALYLATED LIGAND, GLYCOSYLATION AT ASN-105, AND DISULFIDE BOND.

TOP